1-5 of 5
Priscille M. Bourquelot
Close
Sort by
Journal Articles

A Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma.

Jesús F. San-Miguel, MD, PhD, Orhan Sezer, MD, PhD, David Siegel, Andreas Guenther, MD, Maria-Victoria Mateos, MD, PhD, Ian Prosser, MBBS, FRACP, FRCPA, PhD, Michele Cavo, MD, Joan Blade, MD, Mario Boccadoro, MD, Bourras R. Bengoudifa, Martin Klebsattel, PhD, Priscille M. Bourquelot, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3852.
https://doi.org/10.1182/blood.V114.22.3852.3852
Published: 2009
Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) in Adult Patients with Advanced Refractory Multiple Myeloma

Jeffrey Lee Wolf, David Siegel, Jeffrey Matous, Sagar Lonial, Hartmut Goldschmidt, Stefan Schmitt, Ravi Vij, Margarida De Malgalhaes-Silverman, Rafat Abonour, Muhammad Jalaluddin, Martha Li, Katharine Hazell, Priscille M. Bourquelot, Maria-Victoria Mateos, Kenneth C. Anderson, Andrew Spencer, Jean-Luc Harousseau, Joan Bladé
Journal: Blood
Blood (2008) 112 (11): 2774.
https://doi.org/10.1182/blood.V112.11.2774.2774
Published: 2008
Journal Articles

A Phase IB, Multicenter, Open-Label, Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma

Davi d Siegel, Orhan Sezer, Jesus F. San Miguel, Maria-Victoria Mateos, Ian Prosser, Michele Cavo, Muhammad Jalaluddin, Katharine Hazell, Priscille M. Bourquelot, Kenneth C. Anderson, MD
Journal: Blood
Blood (2008) 112 (11): 2781.
https://doi.org/10.1182/blood.V112.11.2781.2781
Published: 2008
Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) for Chronic Phase Chronic Myeloid Leukemia (CML) with Resistance to ≥2 BCR-ABL Tyrosine Kinase Inhibitors

Andrey Zaritskey, Giuliana Alimena, Lech Konopka, Jila Shamsazar, Priscille M. Bourquelot, Muhammad Jalaluddin, Martha Li, Anna Turkina, Gert J. Ossenkoppele, Stuart L. Goldberg, Bayard Powell
Journal: Blood
Blood (2008) 112 (11): 4254.
https://doi.org/10.1182/blood.V112.11.4254.4254
Published: 2008
Journal Articles

A Phase II Study of Oral Panobinostat (LBH589) in Accelerated Phase (AP) or Blast Crisis (BC) Chronic Myeloid Leukemia (CML) Patients Resistant to ≥2 BCR-ABL Tyrosine Kinase Inhibitors

François Guilhot, Viviane Dubruille, Aleksander B. Skotnicki, Andrey Hellmann, Jila Shamsazar, Priscille M. Bourquelot, Muhammad Jalaluddin, Martha Li, Elisabetta Abruzzese, Luke Akard
Journal: Blood
Blood (2008) 112 (11): 4263.
https://doi.org/10.1182/blood.V112.11.4263.4263
Published: 2008